Biggest News Aggregation in the World
๐Ÿ“ฐ Greg Korbutt News

Greg Korbutt News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Greg Korbutt. Real-time updates on events, politics, business and more.

Made-in-Alberta COVID-19 vaccine candidate goes to clinical trials

Date Time Made-in-Alberta COVID-19 vaccine candidate goes to clinical trials A made-in-Alberta COVID-19 vaccine is taking a major step forward on the path to Health Canada approval with the start of a Phase 1 clinical trial. Entos Pharmaceuticals, an Edmonton company led by CEO and University of Alberta researcher John Lewis, has shipped a vaccine for testing to the Canadian Centre for Vaccinology in Halifax. The clinical trial will test the safety of the DNA-based vaccine in 72 participants, s...
South Africa South African Greg Korbutt Gayle Piat John Lewis University Of Alberta

COVID-19 vaccine developed at University of Alberta proceeding to clinical trials

ย  EDMONTON -- An Alberta-developed COVID-19 vaccine using new technology is one step closer to starting clinical trials. John Lewis, University of Alberta professor and CEO of Entos Pharmaceuticals, has shipped a vaccine for further testing to the Canadian Centre for Vaccinology in Halifax โ€“ a step forward toward its Health Canada approval. The made-in-Alberta COVID-19 vaccine will commence its Health Canada Phase 1 human clinical trial with the aim of moving it to a larger Phase 2 trial ...
Greg Korbutt John Lewis University Of Alberta Entos Pharmaceuticals Health Canada Phase Health Canada

Entos Pharmaceuticals Partners with Alberta Cell Therapy Manufacturing and the Ottawa Hospital Research Institute to Manufacture and Ready its COVID-19 DNA Vaccine for Clinical Trials

in the . Entos announces partnership with The Ottawa Hospitals Biotherapeutics Manufacturing Centre (BMC) to fill Covigenix VAX-001 in vials. BMC and ACTM will collaborate to boost Canadas biotherapeutics manufacturing capacity. EDMONTON, AB, Feb. 25, 2021 /CNW/ -ย Entos Pharmaceuticals (Entos), a biotechnology company developing genetic medicines with its Fusogenix nucleic acid delivery platform, is excited to work with Alberta Cell Therapy Manufacturing and The Ottawa Hospitals Biotherapeu...
Greg Korbutt Gayle Piat Duncan Stewart Johnd Lewis John Lewis Entos Pharmaceuticals Inc

CIHR and JDRF funding drives efforts to find new stem cell-based therapies for Type 1 diabetes

Date Time Share CIHR and JDRF funding drives efforts to find new stem cell-based therapies for Type 1 diabetes University of Alberta researchers are among two Canadian research teams chosen for significant new funding from the Government of Canada and JDRF Canada to develop new stem cell-based therapies for treating Type 1 diabetes. The projects will each receive $1.5 million from the Canadian Institutes of Health Research Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD) along with ...
United Kingdom Cristina Maria Nostro Greg Korbutt Patrick Macdonald University Of Toronto University Of Alberta

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science